These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7342082)

  • 1. Factors affecting prostaglandin endoperoxide transformation: antibodies against PGH2.
    Fitzpatrick FA; Pike JE
    Prog Lipid Res; 1981; 20():179-82. PubMed ID: 7342082
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
    Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
    Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
    [No Abstract]   [Full Text] [Related]  

  • 3. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
    Jones RL; Wilson NH
    Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides.
    Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK
    Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin H2 directly lowers human platelet cAMP levels.
    Rybicki JP; Le Breton GC
    Thromb Res; 1983 Jun; 30(5):407-14. PubMed ID: 6310815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovine maternal and fetal circulatory responses to an endoperoxide analog.
    Schwartz DB; Phernetton TM; Stock MK; Rankin JH
    Proc Soc Exp Biol Med; 1982 Oct; 171(1):46-9. PubMed ID: 7145937
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of 1-iodo-3-aminomethyl-5,6,7,8-tetrahydro-2-naphthol (ONO-3122) and prostaglandin H2 on vasopressin-induced osmotic water flow in toad bladder.
    Marumo F
    Experientia; 1982 Jul; 38(7):828-9. PubMed ID: 6809486
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of prostaglandin H2 on perinatal pulmonary circulation.
    Tod ML; Cassin S; McNamara DB; Kadowitz PJ
    Pediatr Res; 1986 Jun; 20(6):565-9. PubMed ID: 3714368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
    Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
    J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of lymphatic contractility by arachidonate metabolites.
    Johnston MG; Gordon JL
    Nature; 1981 Sep; 293(5830):294-7. PubMed ID: 7196995
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiation of itch and flare responses in human skin by prostaglandins E2 and H2 and a prostaglandin endoperoxide analog.
    Hägermark O; Strandberg K; Hamberg M
    J Invest Dermatol; 1977 Dec; 69(6):527-30. PubMed ID: 925375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel arachidonic acid metabolites formed by prostaglandin H synthase.
    Hecker M; Ullrich V; Fischer C; Meese CO
    Eur J Biochem; 1987 Nov; 169(1):113-23. PubMed ID: 3119336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of vascular resistance with endocrine pancreas secretion: the effects of epoxymethano analogs of PGH2.
    Akpan JO; Hurley MC; Pek S; Lands WE
    Prostaglandins Med; 1981 Dec; 7(6):473-81. PubMed ID: 7034020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2.
    Gorman RR; Fitzpatrick FA; Miller OV
    Biochem Biophys Res Commun; 1977 Nov; 79(1):305-13. PubMed ID: 200243
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic studies on Prostanoids. XX. Synthesis of stable (+/-)-prostaglandin H1 analogs.
    Sakai K; Inoue K; Amemiya S; Morita A; Kojima K
    Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1814-9. PubMed ID: 7408058
    [No Abstract]   [Full Text] [Related]  

  • 19. Contractile responses of intrapulmonary vessels from three species to arachidonic acid and an epoxymethano analog of PGH2.
    Gruetter CA; McNamara DB; Hyman AL; Kadowitz PJ
    Can J Physiol Pharmacol; 1978 Apr; 56(2):206-15. PubMed ID: 638873
    [No Abstract]   [Full Text] [Related]  

  • 20. Desensitisation of human platelets against stimulation by thromboxane mimics--reduction in receptor capacity and loss of functional response.
    Thierauch KH; Gabriel D; Prior G; Schillinger E
    Biomed Biochim Acta; 1988; 47(10-11):S75-8. PubMed ID: 2470362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.